Literature DB >> 19048230

Use of bisphosphonates for the treatment of stress fractures in athletes.

Yosuke Shima1, Lars Engebretsen, Junji Iwasa, Katsuhiko Kitaoka, Katsuro Tomita.   

Abstract

A literature review was performed to investigate the potential role of bisphosphonates for the treatment of stress fractures in athletes. Given the inhibitory action on osteoclast-mediated bone resorption, short-term suppression of bone remodeling using bisphosphonates could potentially treat stress fractures and prevent stress fractures from becoming regular fractures. To date, while there are some animal studies showing the scientific basis of bisphosphonates on stress fractures, there is still no conclusive evidence to prove any effect of bisphosphonates on stress fracture healing in humans. Further well-designed clinical trials should be carried out to establish their usefulness and safety. Until the results are available, it is prudent to limit the use of bisphosphonates for the treatment of stress fractures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048230     DOI: 10.1007/s00167-008-0673-0

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  81 in total

1.  Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients.

Authors:  Daniele Santini; Bruno Vincenzi; Sara Galluzzo; Fabrizio Battistoni; Laura Rocci; Olga Venditti; Gaia Schiavon; Silvia Angeletti; Federica Uzzalli; Michele Caraglia; Giordano Dicuonzo; Giuseppe Tonini
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

2.  Safety and compliance of intravenous and oral dosing regimens.

Authors:  Graham Jackson
Journal:  Oncologist       Date:  2005-05

Review 3.  Pharmacologic agents in fracture healing.

Authors:  Michael C Koester; Kurt P Spindler
Journal:  Clin Sports Med       Date:  2006-01       Impact factor: 2.182

4.  Risk factors for clinical stress fractures in male military recruits: a prospective cohort study.

Authors:  Ville-Valtteri Välimäki; Henrik Alfthan; Eero Lehmuskallio; Eliisa Löyttyniemi; Timo Sahi; Harri Suominen; Matti J Välimäki
Journal:  Bone       Date:  2005-08       Impact factor: 4.398

5.  The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.

Authors:  Kuo-An Lai; Wun-Jer Shen; Chyun-Yu Yang; Chung-Jung Shao; Jui-Ting Hsu; Ruey-Mo Lin
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

6.  Effect of zoledronic acid in an L6-L7 rabbit spine fusion model.

Authors:  Rick Bransford; Elisabeth Goergens; Julie Briody; Negin Amanat; Andrew Cree; David Little
Journal:  Eur Spine J       Date:  2006-09-12       Impact factor: 3.134

7.  The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.

Authors:  A H A Kurth; C Eberhardt; S Müller; M Steinacker; M Schwarz; F Bauss
Journal:  Bone       Date:  2005-08       Impact factor: 4.398

8.  Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.

Authors:  S M Ali; F J Esteva; G Hortobagyi; H Harvey; J Seaman; R Knight; L Costa; A Lipton
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

9.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

10.  Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.

Authors:  M Saito; S Mori; T Mashiba; S Komatsubara; K Marumo
Journal:  Osteoporos Int       Date:  2008-03-29       Impact factor: 5.071

View more
  6 in total

1.  The management of sacral stress fractures: current concepts.

Authors:  Valentina Longhino; Cristina Bonora; Valerio Sansone
Journal:  Clin Cases Miner Bone Metab       Date:  2011-09

2.  Detection and residence time of bisphosphonates in bone of horses.

Authors:  Heather K Knych; Jennifer Janes; Laura Kennedy; Daniel S McKemie; Rick M Arthur; Monika A Samol; Francisco A Uzal; Mary Scollay
Journal:  J Vet Diagn Invest       Date:  2022-01       Impact factor: 1.279

3.  Multiple stress fractures of unilateral femur: A case report.

Authors:  Mao-Ting Tang; Chun-Feng Liu; Jin-Lian Liu; Zhen Wang
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

4.  Stress fractures: definition, diagnosis and treatment.

Authors:  Diego Costa Astur; Fernando Zanatta; Gustavo Gonçalves Arliani; Eduardo Ramalho Moraes; Alberto de Castro Pochini; Benno Ejnisman
Journal:  Rev Bras Ortop       Date:  2015-12-30

Review 5.  Is the Use of Bisphosphonates Putting Horses at Risk? An Osteoclast Perspective.

Authors:  Fernando B Vergara-Hernandez; Brian D Nielsen; Aimee C Colbath
Journal:  Animals (Basel)       Date:  2022-07-03       Impact factor: 3.231

Review 6.  Current perspectives on the etiology and manifestation of the "silent" component of the Female Athlete Triad.

Authors:  Rebecca J Mallinson; Mary Jane De Souza
Journal:  Int J Womens Health       Date:  2014-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.